Defence Therapeutics Inc. DTCFF
Set alert
0.26 USD 0.00 -0.42%
At close · Oct 30
0.26 Day range 0.26
0.2418 52-week range 0.7787
- YTD
- -53.37%
- 1 year
- -55.58%
- Open
- 0.26
- Prev close
- 0.2611
- Mkt cap
- 19.70M
- Vol
- 9.96K
- Avg vol
- 10.15K
- EPS
- -0.08
- P/E
- 0.00
More statistics
- Low
- 0.26
- High
- 0.26
Financial health
Altman Z-Score
-1.93 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -14.7×
FY 2019 5y median -14.7× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B -37.9×
FY 2019 5y median -11.1× FY 2025
P/FCF -12.6×
FY 2019 5y median -12.6× FY 2025
EV/EBITDA -13.1×
FY 2019 5y median -3.3× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -7.9%
FY 2019 5y median -7.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE 400.0%
FY 2019 5y median 368.1% FY 2025
ROIC -1205.8%
FY 2019 5y median -52.1% FY 2025
ROA -242.0%
FY 2019 5y median -242.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 76.3%
FY 2019 FY 2025
EPS (diluted) 82.7%
FY 2019 FY 2025
Free Cash Flow 33.2%
FY 2019 FY 2025
Financial Health
Current Ratio 0.5×
FY 2019 5y median 0.6× FY 2025
Quick Ratio 0.5×
FY 2019 5y median 0.6× FY 2025
Debt / Equity -1.5×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2019 5y median 0.0× FY 2025
Interest Coverage -9.3×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-06-30